Historical record - last NADAC effective date: 8/17/2022
Product Information
QSYMIA 15 MG-92 MG CAPSULE is a brand product labeled by Vivus LLC, priced at $6.3680 per EA under NDC 62541020430. Its NADAC has been published 454 times since Apr 23, 2014.
FDA first approved this application on Jul 17, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15; 92 mg/1; mg/1
Manufacturer
Vivus LLCNDC
62541020430
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/17/2022
Active Ingredients
PHENTERMINE HYDROCHLORIDE; TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA022580FDA Approved
7/17/2012
TE Code
AB
On Market Since
9/17/2012
Pharmacological Classes
Price Statistics
The NADAC for QSYMIA 15 MG-92 MG CAPSULE has been published 454 times since Apr 23, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3680 per EA |
|---|---|
| All-time high | $6.5825 (Mar 11, 2015) |
| All-time low | $6.3442 (Apr 17, 2019) |
| Median price | $6.4033 |
| Average price | $6.4092 |
| Largest weekly change | +2.8% (Oct 22, 2014) |
| Weeks tracked | 454 |
| Tracking since | Apr 23, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-0.4%
All
-0.6%
Last surveyed Dec 28, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QSYMIA 15 MG-92 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QSYMIA 15 MG-92 MG CAPSULE, manufactured by Vivus LLC, is $6.3680 per EA (NDC 62541020430), effective Dec 28, 2022.
How has the price of QSYMIA 15 MG-92 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QSYMIA 15 MG-92 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 454 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for QSYMIA 15 MG-92 MG CAPSULE?
Since Apr 23, 2014, the NADAC for QSYMIA 15 MG-92 MG CAPSULE has ranged from a low of $6.3442 (Apr 17, 2019) to a high of $6.5825 (Mar 11, 2015), with a median of $6.4033 per EA.
Are there cheaper alternatives to QSYMIA 15 MG-92 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE, is $3.1846 per EA — about 50% below QSYMIA 15 MG-92 MG CAPSULE.
Who manufactures QSYMIA 15 MG-92 MG CAPSULE?
QSYMIA 15 MG-92 MG CAPSULE (NDC 62541020430) is labeled by Vivus LLC, and CMS classifies it as a brand product.